From hPSC to Immune Cells: Reagents for hPSC-Derived Cell and Gene Therapies

Dr. Kimberly Snyder gives an overview of STEMCELL’s hPSC culture media, including TeSR™-AOF, a novel animal origin-free (AOF) hPSC maintenance medium that supports optimized cell quality, improved performance, and reproducibility across all cell lines. The data was originally presented at ISSCR 2021. Dr. Snyder is a senior scientist in the pluripotent stem cell research group at STEMCELL Technologies.

Dr. Kimberly Snyder gives an overview of STEMCELL’s hPSC culture media, including TeSR™-AOF, a novel animal origin-free (AOF) hPSC maintenance medium that supports optimized cell quality, improved performance, and reproducibility across all cell lines. The data was originally presented at ISSCR 2021. Dr. Snyder is a senior scientist in the pluripotent stem cell research group at STEMCELL Technologies.

This presentation and the following Q&A were moderated by Dr. Glyn Stacey from EuroStemCell and Dr. Adam Hirst from STEMCELL Technologies. It was part of the workshop “From hPSCs to Immune Cells”, hosted together with the London Stem Cell Network. During the event, scientists and experts presented on advancements in hPSC culture, the generation of immune cells, and the demands of cell therapy research. Explore the full series here >
Publish Date: February 09, 2022